The South African Department of health forecasts supply challenges of insulin pen devices for diabetes management, and has advised health facilities to ration the distribution of insulin pens across the country. Reacting to this development, the global medical humanitarian organisation, Doctors Without Borders or MSF, is calling on Danish pharmaceutical corporation Novo Nordisk and other manufacturers of insulin pens to acknowledge their responsibility and take immediate action to ensure a continuous supply of insulin pens to South Africa. The country has 4.2 million people with diabetes. MSF held a two-part webinar to discuss ways to make access to insulin and newer diabetes medicines possible for all people with diabetes. For more Udo Carelse spoke to  Candice Sehoma, Campaign Advocacy Advisor at  Médecins Sans Frontières, also known as Doctors Without Borders